About
Noninvasive Stone Treatment
Areas of Focus
Categories
Uncategorized Medical DeviceBiotech
Team (6)
Adam Maxwell
University of Washington, Seattle
SonoMotion
team_member
Barbrina Dunmire
University of Washington, Seattle
SonoMotion
team_member
Doug Corl
Chief Technology Officer
SonoMotion
executive
Emily Hergenreter
VP of Clinical Affairs
SonoMotion
executive
Michael Bailey
University of Washington, Seattle
SonoMotion
team_member
Oren Levy
Chief Executive Officer, Co-Founder
SonoMotion
executivefounder
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
186
By Phase
NA: 2
By Status
ACTIVE_NOT_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05701098Lead Sponsor
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
NAActive, not recruiting
116 participants
Started: Oct 9, 2023 · Completed: Jan 31, 2026
NCT03811171Lead Sponsor
Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
NARecruiting
70 participants
Started: Aug 20, 2019 · Completed: Mar 30, 2027
Locations (1)
Headquarters
San Mateo, CA, United States
Map
Loading map...